No cannabis product is approved to treat ADHD in adults. The FDA has approved no cannabis or CBD drug for ADHD, or for any psychiatric disorder. Published reviews report no large randomized controlled trial of cannabis for ADHD. Access has grown. Evidence has not.
What the studies show
A 2017 retrospective chart review tracked 59 adults with ADHD who used cannabis. Patients rated less hyperactivity and less impulsivity. Attention scores did not change. The study had no control group, no blinding, and no placebo. Self-report drove the results.
Cannabis for ADHD Dosage: There Is No Standard Dose
Later reviews repeat that point. Case reports and small surveys cannot separate cannabis from expectation, poor sleep, or concurrent stimulant use.
How many adults have ADHD
The CDC reported 15.5 million US adults with an ADHD diagnosis in 2023. That is about 6% of the adult population. Cannabis use is more common among adults with ADHD than among adults without, per survey data cited in the same literature.
Can Cannabis Worsen ADHD? A Straight Answer
Why adults ask about it
- Stimulant supply. Amphetamine mixed salts entered the FDA drug shortage list in October 2022 and stayed listed into 2024.
- Cost. Generic methylphenidate and amphetamine salts vary in price by pharmacy and insurance plan.
- Side effects. Some adults stop stimulants after insomnia, appetite loss, or anxiety.
- Access. Retail stores, delivery, and online ordering put cannabis within minutes of most adults in legal states.
Risks
- Memory and attention. THC impairs short-term memory and reaction time during use.
- Cannabis use disorder. SAMHSA criteria include tolerance, craving, and use that interferes with work, school, or home.
- Anxiety and paranoia. Risk rises with high-THC products and daily use.
- Psychosis. Risk rises with high potency and early, frequent use.
- Drug interactions. Cannabis can change blood levels of some medications.
Legal status
Cannabis is Schedule I under federal law. Many states license adult-use sales. A state license does not make a product an ADHD treatment. The FDA has approved one CBD drug, for rare seizure disorders, and it is not an ADHD drug.
The convenience question
Delivery, store density, and online ordering changed how adults reach cannabis. A person can order a product in minutes and skip a clinic visit. Convenience decides access. It does not answer the clinical question. For ADHD, the clinical question is whether a product reduces symptoms without harm. That question still lacks a large trial.
Steps to take
- Track symptoms for 2 weeks before any change.
- Ask a clinician about approved options: methylphenidate, amphetamines, atomoxetine, viloxazine.
- Disclose cannabis use, including amount, frequency, and THC content.
- Report side effects such as anxiety, memory problems, or sleep changes.
Unknown: which dose, ratio, or product might help any single adult with ADHD. No study has answered that.